CollPlant Biotechnologies (CLGN) Competitors $4.17 -0.06 (-1.42%) (As of 10:19 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends CLGN vs. SGHT, SONX, SKIN, BWAY, ZJYL, KRMD, NVRO, DRTS, LAKE, and PDEXShould you be buying CollPlant Biotechnologies stock or one of its competitors? The main competitors of CollPlant Biotechnologies include Sight Sciences (SGHT), Sonendo (SONX), Beauty Health (SKIN), BrainsWay (BWAY), Jin Medical International (ZJYL), KORU Medical Systems (KRMD), Nevro (NVRO), Alpha Tau Medical (DRTS), Lakeland Industries (LAKE), and Pro-Dex (PDEX). These companies are all part of the "medical equipment" industry. CollPlant Biotechnologies vs. Sight Sciences Sonendo Beauty Health BrainsWay Jin Medical International KORU Medical Systems Nevro Alpha Tau Medical Lakeland Industries Pro-Dex Sight Sciences (NASDAQ:SGHT) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, community ranking, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends. Do insiders and institutionals hold more shares of SGHT or CLGN? 55.5% of Sight Sciences shares are owned by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are owned by institutional investors. 28.9% of Sight Sciences shares are owned by company insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in SGHT or CLGN? CollPlant Biotechnologies received 120 more outperform votes than Sight Sciences when rated by MarketBeat users. Likewise, 59.13% of users gave CollPlant Biotechnologies an outperform vote while only 29.09% of users gave Sight Sciences an outperform vote. CompanyUnderperformOutperformSight SciencesOutperform Votes1629.09% Underperform Votes3970.91% CollPlant BiotechnologiesOutperform Votes13659.13% Underperform Votes9440.87% Which has more risk and volatility, SGHT or CLGN? Sight Sciences has a beta of 2.74, suggesting that its stock price is 174% more volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Does the media refer more to SGHT or CLGN? In the previous week, Sight Sciences had 3 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 3 mentions for Sight Sciences and 0 mentions for CollPlant Biotechnologies. Sight Sciences' average media sentiment score of 0.57 beat CollPlant Biotechnologies' score of 0.00 indicating that Sight Sciences is being referred to more favorably in the media. Company Overall Sentiment Sight Sciences Positive CollPlant Biotechnologies Neutral Do analysts prefer SGHT or CLGN? Sight Sciences presently has a consensus target price of $5.50, suggesting a potential upside of 47.85%. CollPlant Biotechnologies has a consensus target price of $11.00, suggesting a potential upside of 163.79%. Given CollPlant Biotechnologies' stronger consensus rating and higher possible upside, analysts clearly believe CollPlant Biotechnologies is more favorable than Sight Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sight Sciences 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00CollPlant Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Is SGHT or CLGN more profitable? Sight Sciences has a net margin of -63.30% compared to CollPlant Biotechnologies' net margin of -2,535.70%. Sight Sciences' return on equity of -47.28% beat CollPlant Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Sight Sciences-63.30% -47.28% -32.72% CollPlant Biotechnologies -2,535.70%-65.98%-54.37% Which has better valuation & earnings, SGHT or CLGN? CollPlant Biotechnologies has lower revenue, but higher earnings than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than CollPlant Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSight Sciences$81.06M2.33-$55.55M-$1.02-3.65CollPlant Biotechnologies$10.96M4.36-$7.02M-$1.54-2.71 SummarySight Sciences beats CollPlant Biotechnologies on 10 of the 19 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLGN vs. The Competition Export to ExcelMetricCollPlant BiotechnologiesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$47.75M$9.70B$5.07B$8.80BDividend YieldN/A1.10%4.99%4.07%P/E Ratio-2.7115.9889.5613.60Price / Sales4.3630.301,224.8087.40Price / CashN/A23.2339.4536.27Price / Book1.694.826.976.33Net Income-$7.02M$182.72M$119.04M$225.93M7 Day Performance-1.88%2.76%-1.78%-0.96%1 Month Performance6.38%-3.62%-3.59%1.06%1 Year Performance-25.54%-2.10%31.64%26.59% CollPlant Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLGNCollPlant Biotechnologies1.8582 of 5 stars$4.17-1.4%$11.00+163.8%-24.2%$47.75M$10.96M-2.7170Upcoming EarningsSGHTSight Sciences2.5293 of 5 stars$3.72-0.3%$5.50+47.8%+63.6%$188.83M$81.06M0.00210SONXSonendoN/A$2.16+1.4%N/A+815.3%$180.60M$44.40M-4.80250Positive NewsGap UpSKINBeauty Health2.7023 of 5 stars$1.41-5.4%$2.55+80.9%-36.3%$174.87M$398M0.001,030Analyst RevisionPositive NewsBWAYBrainsWay3.9884 of 5 stars$9.76-0.7%$13.17+34.9%+103.9%$162.80M$31.78M98.31120Gap UpZJYLJin Medical InternationalN/A$1.05+4.0%N/A-94.1%$162.75M$19.82M0.00245Positive NewsKRMDKORU Medical Systems2.0253 of 5 stars$3.50-4.1%$4.13+17.9%+60.1%$160.44M$28.52M0.0080NVRONevro2.8885 of 5 stars$4.27+0.9%$9.10+113.1%-74.5%$160.00M$425.17M-2.241,215Analyst UpgradeDRTSAlpha Tau Medical2.3971 of 5 stars$2.30flat$8.00+248.6%-20.7%$159.89MN/A0.0080LAKELakeland Industries4.4003 of 5 stars$21.57+2.0%$26.50+22.9%+44.7%$159.62M$124.69M88.081,750News CoveragePDEXPro-Dex1.5482 of 5 stars$46.20-3.0%$52.00+12.6%+174.5%$150.61M$53.84M30.93140 Related Companies and Tools Related Companies Sight Sciences Competitors Sonendo Competitors Beauty Health Competitors BrainsWay Competitors Jin Medical International Competitors KORU Medical Systems Competitors Nevro Competitors Alpha Tau Medical Competitors Lakeland Industries Competitors Pro-Dex Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CLGN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share CollPlant Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLGN Stock Alerts